Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified

scientific article published on 07 November 2008

Rituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.LEUKRES.2008.09.034
P698PubMed publication ID18995899

P2093author name stringToshiaki Hanafusa
Takayuki Takubo
Motomu Tsuji
Satoshi Hara
Shoko Nakayama
Taiji Yokote
Takuji Miyoshi
Toshikazu Akioka
Yuji Hirata
Kichinosuke Kobayashi
P433issue6
P921main subjectrituximabQ412323
peripheral T-cell lymphomaQ7168693
P304page(s)e13-6
P577publication date2008-11-07
P1433published inLeukemia ResearchQ15716445
P1476titleRituximab for the treatment of CD20-positive peripheral T-cell lymphoma, unspecified
P478volume33

Reverse relations

cites work (P2860)
Q42916603CD20-positive T-cell Lymphoma with Indolent Clinical Behaviour
Q38562233CD20-positive primary gastric T-cell lymphoma poorly responding to initial treatment with rituximab plus CHOP, and a literature review
Q91087458CD20-positive primary nasal peripheral T-cell lymphoma: An analysis of one case and review of the literature
Q41461351CD20dim-positive T-cell large granular lymphocytic leukemia in a patient with concurrent hairy cell leukemia and plasma cell myeloma.
Q35565675Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20

Search more.